Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTL
3201
Postal Realty Trust
PSTL
$394M
| $106K | ﹤0.01% |
7,974
-6,738
| -46% | -$89.6K |
|
|
SLN
3202
Silence Therapeutics
SLN
$245M
| $106K | ﹤0.01% |
5,570
| – | – |
|
3203
Forafric Global
AFRI
$228M
| $105K | ﹤0.01% |
9,881
-1,697
| -15% | -$18K |
|
3204
ALX Oncology
ALXO
$66.4M
| $105K | ﹤0.01% |
17,317
-11,318
| -40% | -$68.6K |
|
3205
eHealth
EHTH
$124M
| $105K | ﹤0.01% |
23,221
-15,307
| -40% | -$69.2K |
|
3206
RBB Bancorp
RBB
$334M
| $105K | ﹤0.01% |
5,570
-5,582
| -50% | -$105K |
|
|
LGO
3207
Largo
LGO
$101M
| $104K | ﹤0.01% |
56,080
| – | – |
|
3208
Larimar Therapeutics
LRMR
$347M
| $104K | ﹤0.01% |
14,251
-3,953
| -22% | -$28.8K |
|
3209
Puma Biotechnology
PBYI
$234M
| $104K | ﹤0.01% |
31,651
+14,327
| +83% | +$47.1K |
|
3210
Precigen
PGEN
$1.22B
| $104K | ﹤0.01% |
65,212
-48,084
| -42% | -$76.7K |
|
3211
Zegna
ZGN
$2.25B
| $104K | ﹤0.01% |
8,744
-1,804
| -17% | -$21.5K |
|
|
TWKS
3212
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $103K | ﹤0.01% |
36,627
-47,021
| -56% | -$132K |
|
3213
Abacus Life
ABL
$620M
| $102K | ﹤0.01% |
+11,831
| New | +$102K |
|
3214
ACNB Corp
ACNB
$471M
| $102K | ﹤0.01% |
2,795
-2,951
| -51% | -$108K |
|
3215
Brookfield Asset Management
BAM
$91.8B
| $102K | ﹤0.01% |
2,665
-15,244
| -85% | -$583K |
|
3216
Hamilton Insurance Group
HG
$2.38B
| $102K | ﹤0.01% |
6,102
-14,609
| -71% | -$244K |
|
3217
Cartesian Therapeutics
RNAC
$258M
| $102K | ﹤0.01% |
3,762
-203
| -5% | -$5.5K |
|
3218
Target Hospitality
TH
$879M
| $102K | ﹤0.01% |
11,692
-17,244
| -60% | -$150K |
|
|
IGMS
3219
DELISTED
IGM Biosciences
IGMS
| $101K | ﹤0.01% |
14,527
-4,527
| -24% | -$31.5K |
|
3220
Legacy Housing
LEGH
$657M
| $101K | ﹤0.01% |
4,399
-5,655
| -56% | -$130K |
|
3221
Seneca Foods Class A
SENEA
$763M
| $101K | ﹤0.01% |
1,756
-2,629
| -60% | -$151K |
|
3222
The ONE Group
STKS
$84.5M
| $101K | ﹤0.01% |
23,928
-7,973
| -25% | -$33.7K |
|
3223
Trevi Therapeutics
TRVI
$1.14B
| $101K | ﹤0.01% |
33,915
-1,280
| -4% | -$3.81K |
|
|
CMLS
3224
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $101K | ﹤0.01% |
49,337
| – | – |
|
3225
Ranpak Holdings
PACK
$412M
| $100K | ﹤0.01% |
15,655
-23,358
| -60% | -$149K |
|